MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Visninger
• 07/02/23
0
0
Indlejre
administrator
Abonnenter
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer